CA License #01355979
Jennifer Vergara joined Newmark as Executive Managing Director in 2016. She and her partner Mary Hines have together represented more than 12 million square feet of life science transactions. Vergara has consistently been ranked as a top producer.
Vergara has represented a wide range of companies in need of laboratory space including diagnostics, pharmaceutical, medical device, alternative energy, alternative commodities and life science venture funds. Her in-depth experience in the field allows her to quickly understand her clients’ facility needs and find the best creative outcome for each tenant.
Vergara and Hines approach each client as a strategic long-term partnership and develop a specific plan for addressing the client’s real estate objectives. By leveraging the strength of their market knowledge and experience, they provide the most effective and competitive outcome for their clients.
Vergara’s enthusiasm, results-driven outlook and passion for the business have aided in her longstanding and proven track record. Vergara prides herself on her work ethic and integrity.
Prior to Newmark, Vergara worked for more than seven years at Kidder Matthews, where she served as an Executive Vice President. She began her real estate career at CresaPartners, where she served as a broker for nearly six years.
Partial Client List
- Alexandria Real Estate Equities
- Applied Molecular Transport
- Arcus Biosciences
- Astellas Ventures
- Denali Therapeutics
- DiCE Molecules
- Forty Seven Inc.
- Gilead Sciences
- Iconic Therapeutics
- Ideaya Biosciences
- Pliant Therapeutics
- Prothena Biosciences
- Principal Financial Group
- R2M Pharma
- Refuge Biosciences
- Taiho Pharmaceuticals
- The Column Group
- Top 10 Producer, Newmark, 2017-2021
- Top producer companywide, Kidder Matthews, 2015
- Multiple-year Top 10 Producer, Kidder Mathews
Vergara is a graduate of Santa Clara University, where she earned a Bachelor of Science degree in finance and Spanish studies.